With no revenue and no history, investors are not asking you to be certain. They are judging how fast and cheaply you can turn unknowns into evidence. Here is how to show them that method.
A bank can lend against a building. A public investor can buy a stock with a decade of filed results behind it. A founder with a prototype, a spreadsheet and a good story offers neither, and still asks someone to hand over money. It is fair to wonder what the investor thinks they are buying.
The best answer is a rate of learning. When revenue and history are absent, the investor is underwriting how quickly and cheaply this particular founder can shrink what nobody yet knows. Confidence is then the visible presence of a method for retiring the largest risks, and a founder can build that method deliberately, even with almost nothing.
Missing history is unpriced uncertainty
Revenue does a quiet job in a financing conversation. It answers dozens of questions at once: does anyone want this, will they pay this price, can the company deliver, do customers come back. A track record does something similar for the people. Take both away and the questions remain, with nothing answering them. The investor cannot ignore them, so the uncertainty gets priced one way or another, usually through a lower valuation, tighter terms, a smaller check or a polite pass.
With direct evidence missing, investors reach for proxies, and three come up repeatedly. Founder-market fit asks whether this person has a reason to understand the problem better than a stranger would, through years in the industry, a relationship with the buyers or an unusual vantage point. Quality of reasoning asks whether the steps from problem to business connect, and whether the founder knows which step is weakest. Speed of learning asks what the founder knows now that they did not know at the last meeting.
Each proxy is imperfect, and fair-minded investors know it. Founder-market fit can be a flattering story told after the fact, fluent reasoning can be rehearsed, and some investors lean on charisma more than they admit. But the proxies share a useful property: they can be demonstrated instead of claimed. Anyone can say they learn fast. A sequence of dated questions, tests and revised beliefs is much harder to fake and much easier to believe.
Rank the unknowns before you pitch
Most founders can list their assumptions. Fewer rank them, and the ranking is where the credibility lives. Two questions sort the list: how badly does the business break if this assumption is wrong, and how cheaply could we find out? Assumptions that are both fatal and inexpensive to test go first. Those that are fatal but costly to test come next, and they are usually what the investor's money is for. Everything else can wait.
Take a hypothetical, deliberately not a software business. A founder wants to sell cold-chain storage to small fruit exporters, using a shared refrigerated facility near a port. Her assumptions: exporters will pay a per-pallet fee rather than keep using informal cooling; spoilage at the port is high enough to justify the fee; the facility can be leased on workable terms; power is reliable enough to avoid costly backup; and a buyer abroad will accept fruit handled this way without reinspection.
Ranked by consequence and cost to test, the order is clear. Whether exporters will pay is fatal and cheap to probe. Whether spoilage is as bad as she believes is fatal and also cheap, since she can follow a few consignments and record temperatures and rejections. Power reliability is serious but answerable by logging outages for a few weeks. The lease and the foreign buyer's acceptance are slower and harder, so they stay on the list, labeled unresolved and tied to what the capital would fund.
She then designs three time-boxed tests. Over four weeks she rents space in an existing cold room for a handful of pallets from two exporters who agree to a pre-set fee. She logs temperature on every consignment and compares rejection at the destination with the exporters' usual outcomes. And she asks a buyer abroad, in writing, what documentation would satisfy them. The cost is small. What matters is the written plan with a threshold fixed before the test runs, for instance that rejection must fall below what the exporters normally experience for the test to count as a pass. An investor can check the logger data, call the exporters and read the buyer's reply, so the evidence stands whether or not the investor trusts her.
Two disciplines carry the weight. Time-boxing stops a test from becoming an excuse to delay. Setting the pass mark in advance guards against the most common self-deception in early ventures, deciding afterward that whatever happened was a success. Investors have watched many founders do it. A founder who says "we expected at least this, we got less, and here is what we changed" is demonstrating the very rate of learning the investor is trying to price.
Each capital type reads risk differently
The same evidence lands differently depending on who reads it, because each kind of capital is exposed to a different loss. A useful rule is to ask what the provider will be blamed for if this goes wrong, then show that you have thought about exactly that.
Angels bet on the person and the path
An angel is often investing personal money after a handful of conversations, so the founder's reasoning and grip on the market carry unusual weight. What builds confidence is a short account of the ranked risks, the tests already run and what the next money would resolve. A founder who has put the product in front of real buyers has shown something no deck can. Because angels can move informally, small proof points shared between meetings can shift a decision within days.
Grant makers and DFIs fund delivery
Grant makers and development finance institutions are generally not pricing a return the way an angel is. Their exposure is funds that vanish without producing the promised outcome, and projects that fail through avoidable operating, safeguarding or governance gaps. Confidence comes from a credible delivery plan, a budget that ties each cost to an activity, milestones with evidence of completion, and an honest account of risks and mitigations. Local partnerships, permits in hand and a sensible way of measuring results matter more than a bold growth curve.
Lenders look for something to lean on
A lender with no revenue to analyze needs another source of repayment confidence. Sometimes it is a purchase order from a creditworthy buyer, which turns a hope into a documented receivable once delivery is complete. Sometimes it is a third-party guarantee that absorbs part of the loss, which changes the lender's question from "will this business perform?" to "is the guarantor reliable and are the terms clear?" Sometimes it is collateral. In each case the founder makes the repayment path concrete: who pays, when, under what contract, and what happens if they do not. Debt does not reward optimism. It rewards a clear answer about what happens when plans go wrong.
Confidence signals that quietly backfire
Some common attempts to look confident work against the founder. Inflated projections are the clearest case. A forecast that reaches a huge number by year five says little about the market and a lot about the founder's relationship with evidence. Experienced readers do not politely discount the number; they discount the person who produced it. A modest forecast with visible assumptions, and its most sensitive inputs flagged, shows judgment, which is the scarce thing.
Vague traction claims do similar damage. "Strong interest from customers" and "we're in talks with several major players" invite one follow-up question, and the answer usually deflates the claim. Specificity persuades even when the news is smaller: "Nine of the fourteen buyers we interviewed said they would pilot it, and two signed a paid trial" is something an investor can check, and smaller true statements build more confidence than larger fuzzy ones.
The subtlest error is hiding what is unresolved. Founders fear that naming an open risk will scare investors off, yet diligence exists to find it, and the discovery changes what the investor thinks of the founder. If the founder raised the issue first, the finding confirms their honesty. If the investor found it, a worse question appears: what else was left out? Candor also shows that the founder can tell what is known from what is hoped, which is the core skill of running an early business.
There is a fair counterargument, because investors do respond to conviction and a founder who hedges everything may seem unable to lead. The answer is to separate the vision from the facts. Be unambiguous about where you are going and why it matters, and precise about how much of the route has been verified. Conviction about the destination and humility about the map can coexist.
Sequencing the first meetings
The first conversation has a modest job: leave the investor with an accurate, specific picture and a reason to talk again. Start with the problem and your standing to solve it. Then show the ranked risk list, one page at most, with the top two or three unknowns, the tests you have run and what they showed. Bring the raw evidence for at least one test, such as the logger data, the signed trial agreement or the interview notes, so the investor can see what verifiable looks like. Then say plainly what is still open and how the funding would resolve it.
What to admit matters as much as what to show. Name the one or two assumptions you think most likely to be wrong, and say what you would do if they are. Investors often probe that exact point to see whether the founder has a plan or only a hope. Skip the small doubts, which blur the picture, and admit the ones that could change the decision.
Confidence is built between meetings as much as in them, so treat follow-up as a series of small, dated commitments. Before leaving, agree on one thing the investor wants to see next and offer a date. Send a short note afterward restating what you heard, answering open questions and naming the next test. When the result arrives, send it unprompted, along with what it changed. Over several weeks the investor sees a pattern: a promise made, a test run, a result reported honestly. That pattern is the track record you did not have, produced in miniature.
Marcus, Fundverse's AI, can help you organize your evidence and structure your risk list, and you can keep supporting material in a data room so investors can verify what you claim. Join Fundverse to build and share that evidence in one place.
A track record can start small
The phrase "no track record" suggests a fixed condition, like an empty résumé. It is closer to a quantity that accumulates, and the first units are cheap. A founder who names an unknown, runs a four-week test, reports the result and adjusts has already produced a small record of exactly what investors care about. Repeated three or four times across a few months, it becomes a pattern a stranger can inspect.
That is why certainty is the wrong thing to offer. Investors do not expect it, and they have learned to distrust it. What they can price is a founder who knows precisely where the doubts are, has a cheap way of working through them, and says so without flinching. Offer that, and the absence of revenue stops being the whole story.
Frequently asked questions
Topics
investor confidence
raising capital without revenue
pre-revenue fundraising
riskiest assumptions
early-stage fundraising
grant and DFI funding
first investor meetings
Raising or investing?
Find the right people on the other side of the table, and run the round in one place.

